Loading…
BlackRock Health Sciences Trust is projected to rise to $56.88 by 2027, a +31% move from its current price of $43.49. BME is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $43.20 | $43.51 | $43.83 | +0.05% |
| Aug 3 | $43.09 | $43.53 | $43.98 | +0.10% |
| Aug 4 | $43.01 | $43.55 | $44.10 | +0.14% |
| Aug 5 | $42.95 | $43.57 | $44.21 | +0.19% |
| Aug 6 | $42.89 | $43.59 | $44.31 | +0.24% |
| Aug 7 | $42.85 | $43.62 | $44.40 | +0.29% |
| Aug 8 | $42.81 | $43.64 | $44.48 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $42.81 | $43.64 | $44.48 | +0.34% |
| Week 2 | $42.61 | $43.78 | $44.98 | +0.67% |
| Week 3 | $42.50 | $43.93 | $45.41 | +1.01% |
| Week 4 | $42.42 | $44.08 | $45.80 | +1.35% |
| Week 5 | $42.37 | $44.23 | $46.16 | +1.69% |
| Week 6 | $42.34 | $44.38 | $46.51 | +2.04% |
| Week 7 | $42.33 | $44.53 | $46.84 | +2.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in the public equity markets of the United States, focusing on stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
BlackRock Health Sciences Trust (BME) trades at $43.53 and has a market capitalization of $562.59M. It is ranked 2761 by market cap. The 30-day price range is $41.44 to $45.72, with RSI14 at 60 and moving averages of $41.47 (SMA50) and $40.54 (SMA200). The stock currently shows a bullish technical stance.
A major floor 13.4% below — a decisive break under it would weaken the trend.
The nearest floor, 8.5% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 7.3% above — clearing it would confirm fresh momentum.
Key BME support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BME market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $43.61 | Sell | $43.48 | Buy |
| MA 10 | $43.07 | Buy | $43.25 | Buy |
| MA 20 | $43.06 | Buy | $42.89 | Buy |
| MA 50 | $41.56 | Buy | $41.91 | Buy |
| MA 100 | $40.40 | Buy | $41.15 | Buy |
| MA 200 | $40.57 | Buy | $40.41 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.22 | Neutral |
| Stoch RSI (14) | 47.30 | Neutral |
| CCI (20) | 57.02 | Neutral |
| Williams %R (14) | -31.07 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 2.89 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 68.93 | Neutral |
| TRIX (15) | 0.18 | Buy |
| Awesome (5,34) | 1.27 | Buy |
| Ultimate (7,14,28) | 69.21 | Neutral |
| Momentum (10) | 0.93 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 44.03 | Sell |
| ADX (14) | 24.24 | Buy |
| ATR (14) | 0.30 | Info |
The near-term picture is framed by bullish technical sentiment, with RSI14 at 60, SMA50 at $41.47 and SMA200 at $40.54. The price is contained within a 30-day range of $41.44 to $45.72 and faces support at $39.80 with resistance at $44.04. The 30-day picture is complemented by an annualized volatility of 10% and a current bullish outlook.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $37.67 | $43.49 | $60.36 | 0% | Neutral | |
| $46.64 | $56.88 | $72.49 | +31% | Bullish | |
| $51.10 | $63.50 | $83.15 | +46% | Bullish | |
| $53.75 | $67.85 | $90.75 | +56% | Bullish | |
| $59.20 | $75.73 | $103.13 | +74% | Bullish | |
| $65.67 | $85.04 | $117.66 | +96% | Bullish | |
| $76.40 | $100.06 | $140.41 | +130% | Bullish | |
| $89.25 | $118.12 | $167.91 | +172% | Bullish | |
| $95.65 | $127.86 | $183.94 | +194% | Bullish | |
| $103.47 | $139.63 | $203.12 | +221% | Bullish | |
| $153.58 | $216.17 | $329.59 | +397% | Bullish | |
| $268.78 | $405.78 | $663.27 | +833% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $37.67 | $43.49 | $53.31 | +0.00% |
| September 2026 | $38.70 | $45.38 | $54.42 | +4.34% |
| October 2026 | $38.57 | $45.44 | $54.89 | +0.13% |
| November 2026 | $39.90 | $47.18 | $57.34 | +3.84% |
| December 2026 | $41.63 | $49.39 | $60.36 | +4.68% |
Click any year to see its month-by-month BME forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BME could reach as high as $60.36, with a base case around $43.49 and support toward $37.67 — roughly 0% from $43.49. A consolidation phase looks the most probable path here.
Expect BME to range from $46.64 to $72.49 through 2027. The $56.88 average target implies a +31% move from current prices. That is up +31% on the projected 2026 average. Momentum favours further upside here.
The BME price prediction for 2028 points to an average of $63.50 (low $51.10, high $83.15) — a potential gain of +46% on today's $43.49. Buyers look set to stay in control over this stretch.
In 2029, BME is projected to trade between $53.75 and $90.75, averaging $67.85 — a potential gain of +56% from today's $43.49. That is up +7% on the projected 2028 average. Momentum favours further upside here.
BlackRock Health Sciences Trust's 2030 outlook centres on $75.73, within a $59.20 to $103.13 range. That is up +12% on the projected 2029 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, BME could reach as high as $117.66, with a base case around $85.04 and support toward $65.67 — roughly +96% from $43.49. Momentum favours further upside here.
Expect BME to range from $76.40 to $140.41 through 2032. The $100.06 average target implies a +130% move from current prices. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The BME price prediction for 2033 points to an average of $118.12 (low $89.25, high $167.91) — a potential gain of +172% on today's $43.49. Momentum favours further upside here.
In 2034, BME is projected to trade between $95.65 and $183.94, averaging $127.86 — a potential gain of +194% from today's $43.49. That is up +8% on the projected 2033 average. Buyers look set to stay in control over this stretch.
BlackRock Health Sciences Trust's 2035 outlook centres on $139.63, within a $103.47 to $203.12 range. That is up +9% on the projected 2034 average. That marks a +221% change versus current levels. Momentum favours further upside here.
By 2040, BME could reach as high as $329.59, with a base case around $216.17 and support toward $153.58 — roughly +397% from $43.49. Buyers look set to stay in control over this stretch.
Expect BME to range from $268.78 to $663.27 through 2050. The $405.78 average target implies a +833% move from current prices. That is up +88% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BME today (≈ 22.993792 BME) could be worth
$9,330.45
+$8,330.45 (+833%) by 2050 · US Dollar
Based on the average projected BME price of $405.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BMEwould be worth at today's price.
$1,000 invested in BME on Jul 31, 2025 (≈ 28.137309 BME) would be worth
$1,223.69
+$223.69 (+22.4%) today · 1.22× · US Dollar
Based on a BME entry price of $35.54 vs. today's $43.49.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $42.85 | $1,014.94 | +1.5% |
| 1 month ago | $43.03 | $1,010.69 | +1.1% |
| 3 months ago | $39.39 | $1,104.09 | +10.4% |
| 6 months ago | $42.15 | $1,031.79 | +3.2% |
| 1 year ago | $35.54 | $1,223.69 | +22.4% |
| All time (5.0y) ago | $49.16 | $884.66 | -11.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BME forecast.
Our base-case forecast reaches $87.00 around 2032.
Implied market cap at $87.00: $1.12B
The multi-year forecast shows sustained upside, with the 2026 forecast at min $37.67, avg $43.53, max $60.54 and sentiment Neutral. Beyond 2026, the outlook strengthens, with 2027 avg $57.07 and 2028 avg $63.98, followed by 2029 avg $68.48 and 2030 avg $76.56; 2030 ROI is 75.9 and sentiment is Bullish. Longer horizons remain favorable, with 2040 avg $221.69 and ROI 409.3, and 2050 avg $417.66 with ROI 859.5, all bearing a Bullish sentiment.
These are estimates and not guarantees, and actual results can differ due to market conditions.
Tap a question to reveal the answer.
In 2030, the forecast shows an avg price of $76.56, a min of $59.85, a max of $104.27, roiPct 75.9, sentiment BULLISH.
Forecasts begin Neutral in 2026, then turn Bullish from 2027 onward with rising averages and bullish sentiment through 2050.
Yes. The 2030 max is $104.27.
The current price is $43.53 and the market cap is $562.59M.
The 30-day picture is bullish with RSI 60, SMA50 $41.47, SMA200 $40.54, support $39.80, resistance $44.04, and a 30-day range of $41.44 to $45.72; annualized volatility is 10%.
BlackRock Health Sciences Trust Community Discussion
0Share your BlackRock Health Sciences Trust price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.